查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球感染監測解決方案市場 - 全球規模、份額、趨勢分析、機會和預測報告：按產品、按感染類型、按最終用途、按地區（2019-2029）
市場調查報告書
商品編碼
1227631

全球感染監測解決方案市場 - 全球規模、份額、趨勢分析、機會和預測報告：按產品、按感染類型、按最終用途、按地區（2019-2029）

Infection Surveillance Solutions Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Offering ; By Infection Type ; By End Use ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 478 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球感染監測解決方案市場規模預計到 2022 年為 46991 萬美元，在 2023 年至 2029 年的預測期內以 13.81% 的複合年增長率顯著增長，到 2029 年將達到 11 億美元。預計將達到 52.12 美元百萬。 推動市場增長的主要因素包括醫院獲得性感染 (HAI) 的流行、微生物中抗生素耐藥性的增加以及醫療保健環境中自動化的高度採用。

本報告考察了全球感染監測解決方案市場，概述了市場、市場規模和預測、趨勢、驅動因素和限制因素，並按產品、感染類型、最終用途和地區進行了細分。它提供了全面的信息例如分析和公司簡介。

內容

第一章研究框架

第 2 章執行摘要

第 3 章全球感染監測解決方案市場洞察

  • 行業價值鏈分析
  • DROC 分析
    • 司機
      • 擴大採用抗菌管理計劃
      • 汽車和運輸行業的增長
    • 約束因素
      • 小型醫療機構的引入成本高
      • 隱私和安全問題
    • 機會
      • 醫療保健相關感染 (HAI) 發病率上升推動了對感染監測解決方案的需求
    • 任務
      • 有限的意識和教育
  • 技術進步/最新發展
  • 監管框架
  • 波特的五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭激烈程度

第 4 章全球感染監測解決方案市場概述

  • 市場規模和預測（2019-2029 年）
    • 按金額
  • 市場份額和預測
    • 通過報價
      • 軟件
      • 服務
    • 按感染類型
      • 手術部位感染 (SSI)
      • 血流感染 (BSI)
      • 尿路感染 (UTI)
      • 其他
    • 按最終用途
      • 療養院
      • 醫院
      • 其他（診所、門診手術中心）
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東和非洲

第五章北美感染監測解決方案市場

  • 市場規模和預測（2019-2029 年）
    • 按金額
  • 市場份額和預測
    • 通過報價
    • 按感染類型
    • 按最終用途
    • 按國家
      • 美國
      • 加拿大

第 6 章：歐洲感染監測解決方案市場

  • 市場規模和預測（2019-2029 年）
    • 按金額
  • 市場份額和預測
    • 通過報價
    • 按感染類型
    • 按最終用途
    • 按國家
      • 德國
      • 英國
      • 意大利
      • 法國
      • 西班牙
      • 荷蘭
      • 其他歐洲

第七章亞太感染監測解決方案市場

  • 市場規模和預測（2019-2029 年）
    • 按金額
  • 市場份額和預測
    • 通過報價
    • 按感染類型
    • 按最終用途
    • 按國家
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳大利亞和新西蘭
      • 印度尼西亞
      • 馬來西亞
      • 新加坡
      • 菲律賓
      • 越南
      • 亞太其他地區

第 8 章拉丁美洲的感染監測解決方案市場

  • 市場規模和預測（2019-2029 年）
    • 按金額
  • 市場份額和預測
    • 通過報價
    • 按感染類型
    • 按最終用途
    • 按國家
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他拉丁美洲

第9章：中東和非洲的感染監測解決方案市場

  • 市場規模和預測（2019-2029 年）
    • 按金額
  • 市場份額和預測
    • 通過報價
    • 按感染類型
    • 按最終用途
    • 按國家
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國
      • 卡塔爾
      • 科威特
      • 南非
      • 尼日利亞
      • 阿爾及利亞
      • 其他中東和非洲地區

第10章競爭格局

  • 主要公司及其產品列表
  • 2022 年全球感染監測解決方案公司的市場份額分析
  • 按運營參數進行競爭性基準測試
  • 重大戰略發展（合併、收購、合作等）

第 11 章 COVID-19 對全球感染監測解決方案市場的影響

第12章公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人才、主要競爭對手、聯繫人、戰略展望、SWOT分析）

  • 賽納公司
  • 史詩系統公司
  • 維吉蘭茲公司
  • Becton, Dickinson and Company
  • 總理公司
  • DEB 集團有限公司
  • 強化學習解決方案
  • 百特國際公司 (ICNet International)
  • Gojo 工業公司
  • IBM 公司（Truven 健康分析）
  • 其他有影響力的公司

第 13 章關鍵戰略建議

第 14 章研究方法論

簡介目錄
Product Code: BWC23158

Global Infection Surveillance Solutions Market Size More Than Doubles to Touch USD 1.2 Billion by 2029.

Global infection surveillance solutions market is flourishing because of rising prevalence of hospital-acquired infections and high adoption of antimicrobial stewardship programs.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global infection surveillance solutions market size at USD 469.91 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global infection surveillance solutions market size to grow at a significant CAGR of 13.81% reaching a value of USD 1,152.12 million by 2029. Major growth factors for global infection surveillance solutions market include growing prevalence of hospital-acquired infections (HAIs), increasing antibiotic resistance in microorganisms, and high adoption of automation in healthcare settings. The growing number of procedures conducted around the world has resulted in longer hospital stays. As a result, the number of patients suffering from HAIs is expected to rise. The global market is expected to benefit from this trend. Increasing healthcare investments are also expected to spur the demand for infection surveillance technologies. Also, favorable government measures have contributed to the market expansion. However, high cost of deployment for small healthcare organizations and privacy and security concerns are anticipated to hinder the overall market growth.

Global Infection Surveillance Solutions Market - Overview:

Infection monitoring software supports healthcare facilities, such as hospitals, in reporting patient data to state and federal authorities. This program notifies hospital Internet Protocol (IPs) when an infection occurs, allowing HAI specialists and nurses to treat infected patients and prevent infection epidemics. These solutions are used to identify infections as well as to evaluate prevention actions. They are also required to avoid infections caused by sterilized medical devices and to diagnose antibiotic-resistant organisms. These systems benefit healthcare facilities by providing accurate staff health information, surgical databases, and real-time medical records. Surveillance strategies are employed to control infection patterns. The increasing analytics capabilities of IT systems is assisting the market's growth. Hospitals have emerged as the primary end-user in these sectors due to their high adoption rate for preserving electronic healthcare data and managing real-time pharmacy. Infection monitoring systems are meant to continuously monitor and analyze health-related data to ensure that preventive actions are properly applied. Hospital-acquired illnesses, also known as nosocomial infections, are caused by a variety of factors, including poor hygienic conditions, neglect, weakened patient immunity, the invasion of drug-resistant bacteria, and procedures that can reduce the effectiveness of ongoing treatments.

Impact of COVID-19 on Global Infection Surveillance Solutions Market

COVID-19 had a detrimental impact on infection surveillance solutions market. The pandemic compelled governments to invest extensively in vaccination efforts as well as hospital facilities and staffing. However, the global economic slump has upended government intentions to maintain or grow spending to address a backlog of non-COVID treatment and resolve staffing shortages. According to the Economist Intelligence Unit, total healthcare spending will rise by 4.9% in nominal terms in 2023, owing to higher expenses and wages. Yet, actual spending is anticipated to fall somewhat as it fails to keep up with inflation.

Global Infection Surveillance Solutions Market - By Offering:

By offering, global infection surveillance solutions market is bifurcated into Software and Services segments. The software segment is expected to hold a higher share in global infection surveillance solutions market during the forecast period because of the increasing use of management surveillance software. The software segment includes on-premises and web-based. During the projected period, the web-based software is expected to grow at a faster rate. The rise in sub-segment can be ascribed to its advantages over on-premises software, including as availability in various configurations, rapid return on investment, and real-time analysis. Furthermore, healthcare IT businesses develop unique solutions in data management, analytics, and infrastructure that facilitate the collecting of data from electronic health records (EHR), infection, and epidemic patterns via their software packages.

Competitive Landscape:

Major players operating in global infection surveillance solutions market include: Cerner Corporation, Epic Systems Corporation, VigiLanz Corporation, Becton, Dickinson and Company, Premier Inc., DEB Group Ltd, RL Solutions, Baxter International Inc. (ICNet International), Gojo Industries Inc., and IBM Corporation (Truven Health Analytics). To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Infection Surveillance Solutions Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Infection Surveillance Solutions Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Infection Surveillance Solutions Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Growing Adoption of Antimicrobial Stewardship Programs
      • 3.2.1.2. Increasing Automotive and Transportation Industry
    • 3.2.2. Restraints
      • 3.2.2.1. High Cost of Deployment for Small Healthcare Organizations
      • 3.2.2.2. Privacy and Security Concerns
    • 3.2.3. Opportunities
      • 3.2.3.1. Growing incidences of Healthcare-Associated Infections (HAIs) Driving Demand for Infection Surveillance Solutions
    • 3.2.4. Challenges
      • 3.2.4.1. Limited Awareness and Education
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Infection Surveillance Solutions Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Offering
      • 4.2.1.1. Software
      • 4.2.1.1.1. On-premises
      • 4.2.1.1.2. Web-based
      • 4.2.1.2. Services
      • 4.2.1.2.1. Maintenance and Support
      • 4.2.1.2.2. Consultation and Training
      • 4.2.1.2.3. Implementation Service
    • 4.2.2. By Infection Type
      • 4.2.2.1. Surgical Site Infections (SSI)
      • 4.2.2.2. Blood Stream Infections (BSI)
      • 4.2.2.3. Urinary Tract Infections (UTI)
      • 4.2.2.4. Others
    • 4.2.3. By End Use
      • 4.2.3.1. Long Term Care Facilities
      • 4.2.3.2. Hospitals
      • 4.2.3.3. Others (Clinics, Ambulatory Surgical Centers)
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Infection Surveillance Solutions Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Offering
    • 5.2.2. By Infection Type
    • 5.2.3. By End Use
    • 5.2.4. By Country
      • 5.2.4.1. US
      • 5.2.4.1.1. By Offering
      • 5.2.4.1.2. By Infection Type
      • 5.2.4.1.3. By End Use
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Offering
      • 5.2.4.2.2. By Infection Type
      • 5.2.4.2.3. By End Use

6. Europe Infection Surveillance Solutions Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Offering
    • 6.2.2. By Infection Type
    • 6.2.3. By End Use
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Offering
      • 6.2.4.1.2. By Infection Type
      • 6.2.4.1.3. By End Use
      • 6.2.4.2. UK
      • 6.2.4.2.1. By Offering
      • 6.2.4.2.2. By Infection Type
      • 6.2.4.2.3. By End Use
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Offering
      • 6.2.4.3.2. By Infection Type
      • 6.2.4.3.3. By End Use
      • 6.2.4.4. France
      • 6.2.4.4.1. By Offering
      • 6.2.4.4.2. By Infection Type
      • 6.2.4.4.3. By End Use
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Offering
      • 6.2.4.5.2. By Infection Type
      • 6.2.4.5.3. By End Use
      • 6.2.4.6. The Netherlands
      • 6.2.4.6.1. By Offering
      • 6.2.4.6.2. By Infection Type
      • 6.2.4.6.3. By End Use
      • 6.2.4.7. Rest of Europe
      • 6.2.4.7.1. By Offering
      • 6.2.4.7.2. By Infection Type
      • 6.2.4.7.3. By End Use

7. Asia-Pacific Infection Surveillance Solutions Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Offering
    • 7.2.2. By Infection Type
    • 7.2.3. By End Use
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Offering
      • 7.2.4.1.2. By Infection Type
      • 7.2.4.1.3. By End Use
      • 7.2.4.2. India
      • 7.2.4.2.1. By Offering
      • 7.2.4.2.2. By Infection Type
      • 7.2.4.2.3. By End Use
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Offering
      • 7.2.4.3.2. By Infection Type
      • 7.2.4.3.3. By End Use
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Offering
      • 7.2.4.4.2. By Infection Type
      • 7.2.4.4.3. By End Use
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Offering
      • 7.2.4.5.2. By Infection Type
      • 7.2.4.5.3. By End Use
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Offering
      • 7.2.4.6.2. By Infection Type
      • 7.2.4.6.3. By End Use
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Offering
      • 7.2.4.7.2. By Infection Type
      • 7.2.4.7.3. By End Use
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Offering
      • 7.2.4.8.2. By Infection Type
      • 7.2.4.8.3. By End Use
      • 7.2.4.9. Philippines
      • 7.2.4.9.1. By Offering
      • 7.2.4.9.2. By Infection Type
      • 7.2.4.9.3. By End Use
      • 7.2.4.10. Vietnam
      • 7.2.4.10.1. By Offering
      • 7.2.4.10.2. By Infection Type
      • 7.2.4.10.3. By End Use
      • 7.2.4.11. Rest of APAC
      • 7.2.4.11.1. By Offering
      • 7.2.4.11.2. By Infection Type
      • 7.2.4.11.3. By End Use

8. Latin America Infection Surveillance Solutions Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Offering
    • 8.2.2. By Infection Type
    • 8.2.3. By End Use
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Offering
      • 8.2.4.1.2. By Infection Type
      • 8.2.4.1.3. By End Use
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Offering
      • 8.2.4.2.2. By Infection Type
      • 8.2.4.2.3. By End Use
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Offering
      • 8.2.4.3.2. By Infection Type
      • 8.2.4.3.3. By End Use
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Offering
      • 8.2.4.4.2. By Infection Type
      • 8.2.4.4.3. By End Use
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Offering
      • 8.2.4.5.2. By Infection Type
      • 8.2.4.5.3. By End Use

9. Middle East & Africa Infection Surveillance Solutions Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Offering
    • 9.2.2. By Infection Type
    • 9.2.3. By End Use
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Offering
      • 9.2.4.1.2. By Infection Type
      • 9.2.4.1.3. By End Use
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Offering
      • 9.2.4.2.2. By Infection Type
      • 9.2.4.2.3. By End Use
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Offering
      • 9.2.4.3.2. By Infection Type
      • 9.2.4.3.3. By End Use
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Offering
      • 9.2.4.4.2. By Infection Type
      • 9.2.4.4.3. By End Use
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Offering
      • 9.2.4.5.2. By Infection Type
      • 9.2.4.5.3. By End Use
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Offering
      • 9.2.4.6.2. By Infection Type
      • 9.2.4.6.3. By End Use
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Offering
      • 9.2.4.7.2. By Infection Type
      • 9.2.4.7.3. By End Use
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Offering
      • 9.2.4.8.2. By Infection Type
      • 9.2.4.8.3. By End Use

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Infection Surveillance Solutions Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Infection Surveillance Solutions Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Cerner Corporation
  • 12.2. Epic Systems Corporation
  • 12.3. VigiLanz Corporation
  • 12.4. Becton, Dickinson and Company
  • 12.5. Premier Inc.
  • 12.6. DEB Group Ltd
  • 12.7. RL Solutions
  • 12.8. Baxter International Inc. (ICNet International)
  • 12.9. Gojo Industries Inc.
  • 12.10. IBM Corporation (Truven Health Analytics)
  • 12.11. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations